Search Results - "PASSERI, Jonathan"

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients by Kolte, Dhaval, Vlahakes, Gus J., Palacios, Igor F., Sakhuja, Rahul, Passeri, Jonathan J., Inglessis, Ignacio, Elmariah, Sammy

“…Transcatheter aortic valve replacement (TAVR) has emerged as a safe and effective therapeutic option for patients with severe aortic stenosis (AS) who are at…”
Get full text

Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients by Sawaya, Heloisa, MD, PhD, Sebag, Igal A., MD, Plana, Juan Carlos, MD, Januzzi, James L., MD, Ky, Bonnie, MD, Cohen, Victor, MD, Gosavi, Sucheta, MD, Carver, Joseph R., MD, Wiegers, Susan E., MD, Martin, Randolph P., MD, Picard, Michael H., MD, Gerszten, Robert E., MD, Halpern, Elkan F., PhD, Passeri, Jonathan, MD, Kuter, Irene, MD, Scherrer-Crosbie, Marielle, MD, PhD

“…As breast cancer survival increases, cardiotoxicity associated with chemotherapeutic regimens such as anthracyclines and trastuzumab becomes a more significant…”
Get full text

Temporal Trends in Prevalence of Tricuspid Valve Disease in Hospitalized Patients in the United States by Kolte, Dhaval, Kennedy, Kevin F., Passeri, Jonathan J., Inglessis, Ignacio, Elmariah, Sammy

“…Tricuspid valve disease (TVD), particularly tricuspid regurgitation, is a common valvular pathology that is associated with increased morbidity and mortality…”
Get full text

Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab by Ky, Bonnie, MD, MSCE, Putt, Mary, ScD, Sawaya, Heloisa, MD, PhD, French, Benjamin, PhD, Januzzi, James L., MD, Sebag, Igal A., MD, Plana, Juan Carlos, MD, Cohen, Victor, MD, Banchs, Jose, MD, Carver, Joseph R., MD, Wiegers, Susan E., MD, Martin, Randolph P., MD, Picard, Michael H., MD, Gerszten, Robert E., MD, Halpern, Elkan F., PhD, Passeri, Jonathan, MD, Kuter, Irene, MD, Scherrer-Crosbie, Marielle, MD, PhD

“…Objectives The aim of this study was to determine if individual or multiple biomarkers are associated with cardiotoxicity in patients with breast cancer…”
Get full text

Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction by Khan, Kathleen R., Khan, Omar A., Chen, Chen, Liu, Yuxi, Kandanelly, Ritvik R., Jamiel, Paris J., Tanguturi, Varsha, Hung, Judy, Inglessis, Ignacio, Passeri, Jonathan J., Langer, Nathaniel B., Elmariah, Sammy

“…Afterload from moderate aortic stenosis (AS) may contribute to adverse outcomes in patients with heart failure with reduced ejection fraction (HFrEF). The…”
Get full text

Effect of Availability of Transcatheter Aortic-Valve Implantation on Survival for all Patients With Severe Aortic Stenosis by Chao, Ariel, Picard, Michael H., Passeri, Jonathan J., Cui, Jinghan, Nethery, Rachel C., Wasfy, Jason H.

“…Clinical outcomes for the overall severe aortic stenosis (AS) patient population are not well described because those medically managed are not included in…”
Get full text

Direct Planimetry of Left Ventricular Outflow Tract Area by Simultaneous Biplane Imaging: Challenging the Need for a Circular Assumption of the Left Ventricular Outflow Tract in the Assessment of Aortic Stenosis by Liu, Shiying, Churchill, Jessica, Hua, Lanqi, Zeng, Xin, Rhoades, Valerie, Namasivayam, Mayooran, Baliyan, Vinit, Ghoshhajra, Brian B, Dong, Tony, Dal-Bianco, Jacob P, Passeri, Jonathan J, Levine, Robert A, Hung, Judy

“…Evaluation of aortic stenosis (AS) requires calculation of aortic valve area (AVA), which relies on the assumption of a circular-shaped left ventricular…”
Get full text

Trends in Utilization of Aortic Valve Replacement for Severe Aortic Stenosis by Li, Shawn X., Patel, Nilay K., Flannery, Laura D., Selberg, Alexandra, Kandanelly, Ritvik R., Morrison, Fritha J., Kim, Joonghee, Tanguturi, Varsha K., Crousillat, Daniela R., Shaqdan, Ayman W., Inglessis, Ignacio, Shah, Pinak B., Passeri, Jonathan J., Kaneko, Tsuyoshi, Jassar, Arminder S., Langer, Nathaniel B., Turchin, Alexander, Elmariah, Sammy

“…Despite the rapid growth of aortic valve replacement (AVR) for aortic stenosis (AS), limited data suggest symptomatic severe AS remains undertreated. This…”
Get full text

Severe, Symptomatic Aortic Stenosis: an Update on the Diagnostic and Treatment Tools in Our Arsenal by Crousillat, Daniela, Namasivayam, Mayooran, Passeri, Jonathan J.

“…Purpose of review We aim to provide the cardiovascular clinician with an update on the classification and diagnosis of severe AS and an evidence-based guide to…”
Get full text

Minimally Invasive Nonresectional Mitral Valve Repair Can Be Performed With Excellent Outcomes by Axtell, Andrea L., Moonsamy, Philicia, Dal-Bianco, Jacob P., Passeri, Jonathan J., Sundt, Thoralf M., Melnitchouk, Serguei

“…To review the efficacy of a minimally invasive surgical technique for mitral valve (MV) repair, we analyzed a nonresectional technique for degenerative mitral…”
Get full text

Percutaneous closure of acute aorto‐right ventricular fistula following transcatheter bicuspid aortic valve replacement by Nakamura, Kenta, Passeri, Jonathan J., Inglessis‐Azuaje, Ignacio

“…We report a case of acute aorto‐right ventricular fistula following transcatheter bicuspid aortic valve replacement and subsequent percutaneous closure. The…”
Get full text

Differential Left Ventricular Outflow Tract Remodeling and Dynamics in Aortic Stenosis by Mehrotra, Praveen, MD, Flynn, Aidan W., MD, PhD, Jansen, Katrijn, MD, Tan, Timothy C., MBBS, PhD, Mak, Gary, MD, Julien, Howard M., MD, Zeng, Xin, MD, Picard, Michael H., MD, Passeri, Jonathan J., MD, Hung, Judy, MD

“…Background Left ventricular outflow tract (LVOT) geometry is variable and often elliptical, which can affect aortic valve area calculation in patients with…”
Get full text

Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort A) by Elmariah, Sammy, Palacios, Igor F, McAndrew, Thomas, Hueter, Irene, Inglessis, Ignacio, Baker, Joshua N, Kodali, Susheel, Leon, Martin B, Svensson, Lars, Pibarot, Philippe, Douglas, Pamela S, Fearon, William F, Kirtane, Ajay J, Maniar, Hersh S, Passeri, Jonathan J

“…BACKGROUND—The Placement of Aortic Transcatheter Valves (PARTNER) trial demonstrated similar survival after transcatheter and surgical aortic valve replacement…”
Get full text

Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial by Elmariah, Sammy, Fearon, William F, Inglessis, Ignacio, Vlahakes, Gus J, Lindman, Brian R, Alu, Maria C, Crowley, Aaron, Kodali, Susheel, Leon, Martin B, Svensson, Lars, Pibarot, Philippe, Hahn, Rebecca T, Thourani, Vinod H, Palacios, Igor F, Miller, D Craig, Douglas, Pamela S, Passeri, Jonathan J

“…The authors sought to evaluate the impact of transapical (TA) transcatheter aortic valve replacement (TAVR) on mortality, left ventricular (LV) ejection…”
Get full text

Case 36-2020: A 72-Year-Old Woman with Dark Urine and Weakness by Malhotra, Rajeev, Namasivayam, Mayooran, Ghoshhajra, Brian B, Passeri, Jonathan J, Hoenig, Peter A, Stone, James R

“…A 72-year-old woman who had undergone mechanical mitral-valve and aortic-valve replacements 25 years earlier presented to the hospital with weakness and dark…”
Get full text

Managing Severe Aortic Stenosis in the COVID-19 Era by Tanguturi, Varsha K., Lindman, Brian R., Pibarot, Philippe, Passeri, Jonathan J., Kapadia, Samir, Mack, Michael J., Inglessis, Ignacio, Langer, Nathan B., Sundt, Thoralf M., Hung, Judy, Elmariah, Sammy

“…The novel coronavirus disease-2019 (COVID-19) pandemic has created uncertainty in the management of patients with severe aortic stenosis. This population…”
Get full text

Relation of Subacute Kidney Injury to Mortality After Transcatheter Aortic Valve Implantation by Cigarroa, Ricardo, Shaqdan, Ayman W., Patel, Vaiibhav, Selberg, Alexandra M., Kandanelly, Ritvik R., Erickson, Phoebe, Furman, Deborah, Sodhi, Nishtha, Vatterott, Anna, Palacios, Igor F., Passeri, Jonathan J., Vlahakes, Gus J., Sakhuja, Rahul, Inglessis, Ignacio, Rhee, Eugene P., Lindman, Brian R., Elmariah, Sammy

“…Acute kidney injury after transcatheter aortic valve implantation (TAVI) has been associated with adverse outcomes; however, data are limited on the subacute…”
Get full text

Patient- and Process-Related Contributors to the Underuse of Aortic Valve Replacement and Subsequent Mortality in Ambulatory Patients With Severe Aortic Stenosis by Flannery, Laura, Etiwy, Muhammad, Camacho, Alexander, Liu, Ran, Patel, Nilay, Tavil-Shatelyan, Arpi, Tanguturi, Varsha K, Dal-Bianco, Jacob P, Yucel, Evin, Sakhuja, Rahul, Jassar, Arminder S, Langer, Nathaniel B, Inglessis, Ignacio, Passeri, Jonathan J, Hung, Judy, Elmariah, Sammy

“…Background Many patients with severe aortic stenosis (AS) and an indication for aortic valve replacement (AVR) do not undergo treatment. The reasons for this…”
Get full text

Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy by Shimada, Yuichi J., MD, Passeri, Jonathan J., MD, Baggish, Aaron L., MD, O'Callaghan, Caitlin, NP, Lowry, Patricia A., MS, RN, APRN-BC, Yannekis, Gia, BA, Abbara, Suhny, MD, Ghoshhajra, Brian B., MD, Rothman, Richard D., MD, Ho, Carolyn Y., MD, Januzzi, James L., MD, Seidman, Christine E., MD, Fifer, Michael A., MD

“…Objectives The aim of this study was to evaluate the effects of losartan on left ventricular (LV) hypertrophy and fibrosis in patients with nonobstructive…”
Get full text

Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab by Tan, Timothy C., MD, PhD, Bouras, Souhila, MD, Sawaya, Heloisa, MD, PhD, Sebag, Igal A., MD, Cohen, Victor, MD, Picard, Michael H., MD, Passeri, Jonathan, MD, Kuter, Irene, MD, Scherrer-Crosbie, Marielle, MD, PhD

“…Background Trastuzumab, a HER2 monoclonal antibody, has transformed the prognosis of patients with the aggressive HER2-positive breast cancer type. Trastuzumab…”
Get full text